SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ATHE

Alterity Therapeutics Ltd (NASDAQ:ATHE)

AU · Delayed Price · Currency is USD
Healthcare · Biotechnology
2.01-0.08 (-3.83%)
 
Market cap
$34.1M
Insider Score
Health Score
Analyst consensus
Listed since
Sep 29, 2003
Insider Score
/ 100
ATHE Insider Score

ALTERITY THERAPEUTICS LTD has a live Insider Score.

Scored on 1 qualifying trade from 1 insider in the last 90 days.

Unlock the score

ATHE analyst forecast

ATHE analyst consensus

No analyst ratings in the last 3 months.

ATHE 12-month price target

$10.00+376.2% upsideaverage of 1 firm
$10.00High
$10.00Low

Best analysts covering ATHE

No firm covering ATHE has enough calls with a finished 1Y holding period to rank yet.

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

ATHE analyst ratings

FirmPrice targetAction
Lake Street—$10.00+159.1%—2026-09-15

ATHE earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2025-08-28-0.56-0.34$5.1M$4.1M
2026-02-25-0.25-0.42$1.1M$646K
2026-08-28-0.12-0.05$2.3M$807K
2027-03-04-0.030.00$0$0
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.